The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
Open accessAbstract
Glioblastoma is highly enriched with macrophages, and osteopontin (OPN) expression levels correlate with glioma grade and the degree of macrophage infiltration; thus, we studied whether OPN plays a crucial role in immune modulation. Quantitative PCR, immunoblotting, and ELISA were used to determine OPN expression. Knockdown of OPN was achieved using complementary siRNA, shRNA, and CRISPR/Cas9 techniques, followed by a series of in vitro functional migration and immunological assays. OPN gene-deficient mice were used to examine the roles of non-tumor-derived OPN on survival of mice harboring intracranial gliomas. Patients with mesenchymal glioblastoma multiforme (GBM) show high OPN expression, a negative survival prognosticator. OPN is a potent chemokine for macrophages, and its blockade significantly impaired the ability of glioma cells to recruit macrophages. Integrin αvβ5 (ITGαvβ5) is highly expressed on glioblastoma-infiltrating macrophages and constitutes a major OPN receptor. OPN maintains the M2 macrophage gene signature and phenotype. Both tumor-derived and host-derived OPN were critical for glioma development. OPN deficiency in either innate immune or glioma cells resulted in a marked reduction in M2 macrophages and elevated T cell effector activity infiltrating the glioma. Furthermore, OPN deficiency in the glioma cells sensitized them to direct CD8+ T cell cytotoxicity. Systemic administration in mice of 4-1BB-OPN bispecific aptamers was efficacious, increasing median survival time by 68% (P < 0.05). OPN is thus an important chemokine for recruiting macrophages to glioblastoma, mediates crosstalk between tumor cells and the innate immune system, and has the potential to be exploited as a therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, Q., Hu, B., Hu, X., Kim, H., Squatrito, M., Scarpace, L., deCarvalho, A. C., Lyu, S., Li, P., Li, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.003 · Cited by 1,995
Self-citationRuffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M. T., Pryer, N., Daniel, D., Hwang, E. S., Rugo, H. S., & Coussens, L. M. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.006 · Cited by 1,008
Alexander, B. M., & Cloughesy, T. F. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.0119 · Cited by 788
Osteopontin: role in cell signaling and cancer progression
Rangaswami, H., Bulbule, A., & Kundu, G. C. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.12.005 · Cited by 735
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Self-citationPietras, A., Katz, A. M., Ekström, E. J., Wee, B., Halliday, J. J., Pitter, K. L., Werbeck, J. L., Amankulor, N. M., Huse, J. T., & Holland, E. C. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.005 · Cited by 540
Self-citationGlioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype
Gabrusiewicz, K., Rodriguez, B., Wei, J., Hashimoto, Y., Healy, L. M., Maiti, S. N., Thomas, G., Zhou, S., Wang, Q., Elakkad, A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85841 · Cited by 445
Self-citationThe role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
A Single Kinase Generates the Majority of the Secreted Phosphoproteome
Tagliabracci, V. S., Wiley, S. E., Guo, X., Kinch, L. N., Durrant, E., Wen, J., Xiao, J., Cui, J., Nguyen, K. B., Engel, J. L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.028 · Cited by 337
Bruemmer, D., Collins, A. R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M. C., Blaschke, F., Kintscher, U., Graf, K., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18141 · Cited by 306
Wei, J., Barr, J., Kong, L.-Y., Wang, Y., Wu, A., Sharma, A. K., Gumin, J., Henry, V., Colman, H., Priebe, W., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0734 · Cited by 282
Self-citationWeber, G. F., Zawaideh, S., Hikita, S., Kumar, V. A., Cantor, H., & Ashkar, S. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.4.752 · Cited by 270
miR-124 Inhibits STAT3 Signaling to Enhance T Cell–Mediated Immune Clearance of Glioma
Wei, J., Wang, F., Kong, L.-Y., Xu, S., Doucette, T., Ferguson, S. D., Yang, Y., McEnery, K., Jethwa, K., Gjyshi, O., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4318 · Cited by 253
Self-citationGelderman, K. A., Hultqvist, M., Pizzolla, A., Zhao, M., Nandakumar, K. S., Mattsson, R., & Holmdahl, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31935 · Cited by 239
Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas
Doucette, T., Rao, G., Rao, A., Shen, L., Aldape, K., Wei, J., Dziurzynski, K., Gilbert, M., & Heimberger, A. B. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0028 · Cited by 226
Self-citationHuber, S., Hoffmann, R., Muskens, F., & Voehringer, D. (2010) · Blood · doi:10.1182/blood-2010-02-271981 · Cited by 204
Osteopontin is a marker for cancer aggressiveness and patient survival
Weber, G. F., Lett, G. S., & Haubein, N. C. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605834 · Cited by 190
Differential screening identifies genetic markers of monocyte to macrophage maturation
Krause, S. W., Rehli, M., Kreutz, M., Schwarzfischer, L., Paulauskis, J. D., & Andreesen, R. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.60.4.540 · Cited by 187
Renkl, A. C., Wussler, J., Ahrens, T., Thoma, K., Kon, S., Uede, T., Martin, S. F., Simon, J. C., & Weiss, J. M. (2005) · Blood · doi:10.1182/blood-2004-08-3228 · Cited by 173
Zhu, B., Suzuki, K., Goldberg, H. A., Rittling, S. R., Denhardt, D. T., McCulloch, C. A. G., & Sodek, J. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10394 · Cited by 172
Kale, S., Raja, R., Thorat, D., Soundararajan, G., Patil, T. V., & Kundu, G. C. (2013) · Oncogene · doi:10.1038/onc.2013.184 · Cited by 168
Osteopontin Shapes Immunosuppression in the Metastatic Niche
Sangaletti, S., Tripodo, C., Sandri, S., Torselli, I., Vitali, C., Ratti, C., Botti, L., Burocchi, A., Porcasi, R., Tomirotti, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3334 · Cited by 160
Regulation of T-helper-cell lineage development by osteopontin: the inside story
Cantor, H., & Shinohara, M. L. (2008) · Nature reviews. Immunology · doi:10.1038/nri2460 · Cited by 159
RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells
Mi, Z., Guo, H., Russell, M. B., Liu, Y., Sullenger, B. A., & Kuo, P. C. (2008) · Molecular Therapy · doi:10.1038/mt.2008.235 · Cited by 157
Sreekanthreddy, P., Srinivasan, H., Kumar, D. M., Nijaguna, M. B., Sridevi, S., Marigowda, V., Arivazhagan, A., Balasubramaniam, A., Hegde, A. S., Chandramouli, B. A., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-1077 · Cited by 132
Innate immune functions of microglia isolated from human glioma patients
Hussain, S. F., Yang, D. S., Suki, D., Grimm, E. A., & Heimberger, A. B. (2006) · Journal of Translational Medicine · doi:10.1186/1479-5876-4-15 · Cited by 109
Self-citationLaderach, D. J., Movassagh, M. J., Johnson, A. G., Mittler, R. S., & Galy, A. H. M. (2002) · International Immunology · doi:10.1093/intimm/dxf080 · Cited by 102
Schrand, B., Berezhnoy, A., Brenneman, R., Williams, A. J., Levay, A. K., Kong, L.-Y., Rao, G., Zhou, S., Heimberger, A. B., & Gilboa, E. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0007 · Cited by 98
Self-citationAtai, N. A., Bansal, M., Lo, C., Bosman, J., Tigchelaar, W., Bosch, K. S., Jonker, A., Hamer, P. C. D. W., Troost, D., McCulloch, C. A., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03335.x · Cited by 97
Nyström, T., Dunér, P., & Hultgårdh‐Nilsson, A. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.12.026 · Cited by 91
Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
Jan, H.-J., Lee, C.-C., Shih, Y., Hueng, D., Ma, H.-I., Lai, J.-H., Wei, H., & Lee, H.-M. (2009) · Neuro-Oncology · doi:10.1093/neuonc/nop013 · Cited by 89
Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells
Gao, C., Guo, H., Downey, L., Marroquin, C., Wei, J., & Kuo, P. C. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg139 · Cited by 78
Self-citationLu, D., Yeh, W., Huang, S.-M., Tang, C., Lin, H., & Chou, S.-J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos262 · Cited by 76
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme
Schuhmann, M. U., Zucht, H.-D., Nassimi, R., Heine, G., Schneekloth, C. G., Stuerenburg, H. J., & Selle, H. (2009) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2009.07.010 · Cited by 67
Tumor-Derived Osteopontin Suppresses Antitumor Immunity by Promoting Extramedullary Myelopoiesis
Kim, E., Jeon, I., Seo, H., Park, Y.-J., Song, B., Lee, K.-A., Jang, Y., Chung, Y., & Kang, C. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1482 · Cited by 63
Yan, W., Qian, C., Zhao, P., Zhang, J., Shi, L., Qian, J., Liu, N., Fu, Z., Kang, C., Pu, P., et al. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq006 · Cited by 61
Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment
Szulzewsky, F., Schwendinger, N., Güneykaya, D., Cimino, P. J., Hambardzumyan, D., Synowitz, M., Holland, E. C., & Kettenmann, H. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox165 · Cited by 45
Selective osteopontin knockdown exerts anti‐tumoral activity in a human glioblastoma model
Lamour, V., Mercier, M. L., Lefranc, F., Hagedorn, M., Javerzat, S., Bikfalvi, A., Robert Kiss, A., Castronovo, V., & Bellahcène, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24751 · Cited by 42
Correliation Between Osteopontin Protein Expression and Histological Grade of Astrocytomas
Toy, H., Yavas, O., Eren, O. Ö., et al. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9130-0 · Cited by 26
Schrand, B., Berezhnoy, A., Brenneman, R., Williams, A. J., Levay, A. K., & Gilboa, E. (2015) · OncoImmunology · doi:10.4161/21624011.2014.970918 · Cited by 25
Self-citation
Cited by
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Locati, M., Curtale, G., & Mantovani, A. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012718 · Cited by 2,199
Wen, P. Y., Weller, M., Lee, E. Q., Alexander, B. M., Barnholtz-Sloan, J. S., Barthel, F. P., Batchelor, T. T., Bindra, R. S., Chang, S. M., Chiocca, E. A., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa106 · Cited by 1,168
Self-citationYuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target
Abdelfattah, N., Kumar, P., Wang, C., Leu, J.-S., Flynn, W. F., Gao, R., Baskin, D. S., Pichumani, K., Ijare, O. B., Wood, S. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28372-y · Cited by 465
Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy
Khan, F., Pang, L., Dunterman, M., Lesniak, M. S., Heimberger, A. B., & Chen, P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163446 · Cited by 414
Self-citation
Metadata
- Authors
- Wei, J., Marisetty, A., Schrand, B., Gabrusiewicz, K., Hashimoto, Y., Ott, M., Grami, Z., Kong, L.-Y., Ling, X., Caruso, H., Zhou, S., Wang, Y. A., Fuller, G. N., Huse, J., Gilboa, E., Kang, N., Huang, X., Verhaak, R., Li, S., & Heimberger, A. B.
- Venue
- Journal of Clinical Investigation
- Published
- 2018-11-19
- Volume
- 129
- Issue
- 1
- Pages
- 137-149
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2896996016
- Cited by
- 396
- References
- 40
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.